Optimizing autologous hematopoietic stem cell transplantation for acute leukemia

Autologous hematopoietic stem cell transplantation (ASCT) remains an important postremission treatment for acute leukemia (AL). It is known that some prognostic factors, such as age, cytogenetic and molecular risk stratification, and minimal residual disease (MRD) status, are closely related to clin...

Descripción completa

Detalles Bibliográficos
Autores principales: Pang, Aiming, Huo, Yingying, Shen, Biao, Zheng, Yawei, Jiang, Erlie, Feng, Sizhou, Han, Mingzhe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Concise Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560201/
https://www.ncbi.nlm.nih.gov/pubmed/34724713
http://dx.doi.org/10.1002/sctm.21-0176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560201/
https://www.ncbi.nlm.nih.gov/pubmed/34724713
http://dx.doi.org/10.1002/sctm.21-0176

Ejemplares similares